Drug therapy of lung cancer

Australian Prescriber

Volumn 26, Issue 5, 2003, Pages 103-105

  Boyer, Michael J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Antineoplastics; Chemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; GEMCITABINE; NAVELBINE; PACLITAXEL;

ALOPECIA; ANEMIA; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL TRIAL; DRUG HYPERSENSITIVITY; ERYTHEMA; FEBRILE NEUTROPENIA; FLUID RETENTION; HEARING LOSS; HUMAN; INJECTION PAIN; KIDNEY DISEASE; LETHARGY; LUNG CANCER; LUNG SMALL CELL CANCER; METASTASIS; NAUSEA; NEUROPATHY; NEUTROPENIA; QUALITY OF LIFE; SHORT SURVEY; SIDE EFFECT; THROMBOCYTOPENIA; TINNITUS; VOMITING;

EID: 0141460543     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2003.079     Document Type: Short Survey

References (8)

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. Br Med J 1995;311:899-909.
2. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993;342:19-21.
3. Clarke SJ, Boyer MJ. Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer. Med J Aust 1997;166 Suppl:S14-6.
4. Ellis PA, Smith IE, Hardy JR, Nicolson MC, Talbot DC, Ashley SE, et al. Symptom relief with MPV (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer 1995;71:366-70.
5. Roszkowski K, Pluzanska A, Krzakowski M, Smith AP, Saigi E, Aasebo U, et al. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). Lung Cancer 2000;27:145-57.
6. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346:92-8.
7. Scagliotti GV, De Marinis F, Rinaldi M, Crino L, Gridelli C, Ricci S, et al. Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. J Clin Oncol 2002;20:4285-91.
8. Turrisi AT III, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71.